TWA
CTKB icon

TCI Wealth Advisors’s Cytek Biosciences CTKB Stock Holding History

TCI Wealth Advisors’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-346
Closed -$3.18K – 675
2023
Q1 		$3.18K Buy
+346
New +$3.72K ﹤0.01% 1824

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TCI Wealth Advisors's CTKB Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Cytek Biosciences (CTKB) in Q2 2023, closing a stake of 346 shares — an estimated $3.18K sold.

TCI Wealth Advisors first reported a position in CTKB in Q1 2023 and held it in 1 quarter. The position peaked at $3.18K in Q1 2023. 101 funds tracked by Wall St. Rank hold CTKB as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Cytek Biosciences position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 346 Cytek Biosciences shares in Q2 2023, an estimated $3.18K.
  • TCI Wealth Advisors first reported a position in Cytek Biosciences in Q1 2023 and held it in 1 quarter.
  • TCI Wealth Advisors's Cytek Biosciences position peaked at $3.18K in Q1 2023.
  • 101 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.